These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22541748)

  • 1. Impact of evidence-based cardiac medication on short- and long-term mortality in 7,567 acute coronary syndrome patients in the Gulf RACE-II registry.
    Al-Zakwani I; Sulaiman K; Al Za'abi M; Panduranga P; Al-Habib K; Asaad N; Al Motarreb A; Hersi A; Al Faleh H; Al Saif S; Almahmeed W; Amin H; Alsheikh-Ali A; Al Lawati J; Al Suwaidi J
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):418-25. PubMed ID: 22541748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of evidence-based cardiac drug therapy on mortality in patients with acute coronary syndrome: Findings from the Gulf COAST registry.
    Al-Zakwani I; Zubaid M; Alsheikh-Ali AA; Almahmeed W; Rashed W
    Cardiovasc Ther; 2018 Dec; 36(6):e12463. PubMed ID: 30079461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication use pattern and predictors of optimal therapy at discharge in 8176 patients with acute coronary syndrome from 6 Middle Eastern countries: data from the gulf registry of acute coronary events.
    Al-Zakwani I; Zubaid M; Panduranga P; Rashed W; Sulaiman K; Almahmeed W; Al-Motarreb A; Al Suwaidi J; Amin H
    Angiology; 2011 Aug; 62(6):447-54. PubMed ID: 21421625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of characteristics, management practices, and outcomes of patients between the global registry and the gulf registry of acute coronary events.
    Awad HH; Zubaid M; Alsheikh-Ali AA; Al Suwaidi J; Anderson FA; Gore JM; Goldberg RJ
    Am J Cardiol; 2011 Nov; 108(9):1252-8. PubMed ID: 21880292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of use of combination evidence-based medical therapy after acute coronary syndromes on long-term outcomes.
    Lahoud R; Howe M; Krishnan SM; Zacharias S; Jackson EA
    Am J Cardiol; 2012 Jan; 109(2):159-64. PubMed ID: 22011560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation and outcomes of acute coronary syndromes in the gulf registry of acute coronary events (Gulf RACE).
    Zubaid M; Rashed WA; Al-Khaja N; Almahmeed W; Al-Lawati J; Sulaiman K; Al-Motarreb A; Amin H; Al-Suwaidi J; Al-Habib K
    Saudi Med J; 2008 Feb; 29(2):251-5. PubMed ID: 18246236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics, management, and in-hospital outcomes of diabetic acute coronary syndrome patients in Oman.
    Panduranga P; Sulaiman KJ; Al-Zakwani IS; Al-Lawati JA
    Saudi Med J; 2010 May; 31(5):520-4. PubMed ID: 20464041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-hospital management and mortality in elderly patients with non-ST-segment elevation acute coronary syndromes treated in centers without on-site invasive facilities.
    Dziewierz A; Siudak Z; Rakowski T; Zdzienicka J; Dykla D; Mielecki W; Dubiel JS; Dudek D
    Cardiol J; 2008; 15(5):451-7. PubMed ID: 18810721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of different evidence-based medications and 5-year survival after an acute coronary syndrome: an observational study.
    Wong CK; Tang EW; Herbison P
    Int J Cardiol; 2009 Feb; 132(2):197-202. PubMed ID: 18191242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics, management and outcomes of patients with acute coronary syndrome and prior coronary artery bypass surgery: findings from the second Gulf Registry of Acute Coronary Events.
    Al-Aqeedi R; Sulaiman K; Al Suwaidi J; Alhabib K; El-Menyar A; Panduranga P; Alshiekh-Ali A; Al Saif S
    Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):611-8. PubMed ID: 21920933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
    Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
    Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of long-term use of evidence-based therapies after non-ST-segment elevation acute coronary syndrome. The S-Témoin survey.
    Danchin N; Diévart F; Thébaut JF; Grenier O; Mihci E; Herrmann MA; Ferrières J
    Int J Cardiol; 2009 Mar; 133(1):32-40. PubMed ID: 18375000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice.
    Kassab YW; Hassan Y; Aziz NA; Akram H; Ismail O
    J Eval Clin Pract; 2013 Aug; 19(4):658-63. PubMed ID: 22845427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the public or private status of health care facility in acute coronary syndrome: data from Thai ACS Registry.
    Hutayanon P; Sarakarn P; Buakhamsri A; Boonsom W; Yamwong S
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():98-108. PubMed ID: 18431892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of acute coronary syndromes in developing countries: acute coronary events-a multinational survey of current management strategies.
    ACCESS Investigators
    Am Heart J; 2011 Nov; 162(5):852-859.e22. PubMed ID: 22093201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
    Lee JH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH; Chae SC;
    Am Heart J; 2010 Jun; 159(6):1012-9. PubMed ID: 20569714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.